Jundishapur Journal of Microbiology

Published by: Kowsar

Antimicrobial and Antibiofilm Activity of Human Cationic Antibacterial Peptide (LL-37) and Its Analogs Against Pan-Drug-Resistant Acinetobacter baumannii

Yijie Guo 1 , * , Ling Wang 2 , Jine Lei 3 , Jiru Xu 1 and Lei Han 1
Authors Information
1 Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi’an Jiao Tong University, Xi’an 710061, China
2 Department of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, 723001, China
3 Clinical Laboratory, The First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an Jiao Tong University, Xi’an 710061, China
Article information
  • Jundishapur Journal of Microbiology: March 01, 2017, 10 (3); e35857
  • Published Online: January 15, 2017
  • Article Type: Research Article
  • Received: December 28, 2015
  • Revised: November 15, 2016
  • Accepted: November 21, 2016
  • DOI: 10.5812/jjm.35857

To Cite: Guo Y, Wang L, Lei J, Xu J, Han L. Antimicrobial and Antibiofilm Activity of Human Cationic Antibacterial Peptide (LL-37) and Its Analogs Against Pan-Drug-Resistant Acinetobacter baumannii, Jundishapur J Microbiol. 2017 ; 10(3):e35857. doi: 10.5812/jjm.35857.

Abstract
Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. De Pascale G, Montini L, Pennisi M, Bernini V, Maviglia R, Bello G, et al. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care. 2014; 18(3)[DOI][PubMed]
  • 2. Merino M, Poza M, Roca I, Barba MJ, Sousa MD, Vila J, et al. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb Drug Resist. 2014; 20(4): 259-63[DOI][PubMed]
  • 3. Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007; 44(12): 1577-84[DOI][PubMed]
  • 4. Visca P, Seifert H, Towner KJ. Acinetobacter infection--an emerging threat to human health. IUBMB Life. 2011; 63(12): 1048-54[DOI][PubMed]
  • 5. Japoni-Nejad A, Sofian M, Belkum A, Ghaznavi-Rad E. Nosocomial Outbreak of Extensively and Pan Drug-Resistant Acinetobacter baumannii in Tertiary Hospital in Central Part of Iran. Jundishapur J Microbiol. 2013; 6(8)[DOI]
  • 6. Dettori M, Piana A, Deriu MG, Lo Curto P, Cossu A, Musumeci R, et al. Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol. 2014; 37(2): 185-91[PubMed]
  • 7. Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014; 37(2): 119-27[PubMed]
  • 8. Badave GK, Kulkarni D. Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge. J Clin Diagn Res. 2015; 9(1)-10[DOI][PubMed]
  • 9. Zanetti M, Gennaro R, Skerlavaj B, Tomasinsig L, Circo R. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr Pharm Des. 2002; 8(9): 779-93[PubMed]
  • 10. Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006; 1758(9): 1408-25[DOI][PubMed]
  • 11. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem. 1998; 273(6): 3718-24[PubMed]
  • 12. Feng X, Sambanthamoorthy K, Palys T, Paranavitana C. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides. 2013; 49: 131-7[DOI][PubMed]
  • 13. Kuroda K, Fukuda T, Yoneyama H, Katayama M, Isogai H, Okumura K, et al. Anti-proliferative effect of an analogue of the LL-37 peptide in the colon cancer derived cell line HCT116 p53+/+ and p53. Oncol Rep. 2012; 28(3): 829-34[DOI][PubMed]
  • 14. Okumura K, Itoh A, Isogai E, Hirose K, Hosokawa Y, Abiko Y, et al. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett. 2004; 212(2): 185-94[DOI][PubMed]
  • 15. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81[DOI][PubMed]
  • 16. Isogai E, Isogai H, Matuo K, Hirose K, Kowashi Y, Okumuara K, et al. Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues. Oral Microbiol Immunol. 2003; 18(5): 329-32[PubMed]
  • 17. Ouhara K, Komatsuzawa H, Kawai T, Nishi H, Fujiwara T, Fujiue Y, et al. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother. 2008; 61(6): 1266-9[DOI][PubMed]
  • 18. Harrison JJ, Turner RJ, Ceri H. High-throughput metal susceptibility testing of microbial biofilms. BMC Microbiol. 2005; 5: 53[DOI][PubMed]
  • 19. Sambanthamoorthy K, Gokhale AA, Lao W, Parashar V, Neiditch MB, Semmelhack MF, et al. Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner. Antimicrob Agents Chemother. 2011; 55(9): 4369-78[DOI][PubMed]
  • 20. Sambanthamoorthy K, Sloup RE, Parashar V, Smith JM, Kim EE, Semmelhack MF, et al. Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob Agents Chemother. 2012; 56(10): 5202-11[DOI][PubMed]
  • 21. Duplantier AJ, van Hoek ML. The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds. Front Immunol. 2013; 4: 143[DOI][PubMed]
  • 22. Haisma EM, de Breij A, Chan H, van Dissel JT, Drijfhout JW, Hiemstra PS, et al. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrob Agents Chemother. 2014; 58(8): 4411-9[DOI][PubMed]
  • 23. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003; 149: 3473-84[DOI][PubMed]
  • 24. Dean SN, Bishop BM, van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol. 2011; 11: 114[DOI][PubMed]
  • 25. Dean SN, Bishop BM, van Hoek ML. Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37. Front Microbiol. 2011; 2: 128[DOI][PubMed]
  • 26. Marsh EN, Buer BC, Ramamoorthy A. Fluorine--a new element in the design of membrane-active peptides. Mol Biosyst. 2009; 5(10): 1143-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments